dr. W.J.C. van Beurden
Functie: Longarts
Bereikbaarheid: (053) 487 26 10
BIG Registratie: 79048433801
Aandachtsgebieden
Speciale aandachtsgebieden:
- Obstructieve longziekten (astma, COPD)
Opleiding
| 1991 – 1997 | Studie Geneeskunde: Universiteit van Maastricht |
| 1998 – 2002 | AGNIO longziekten: Catharina ziekenhuis Eindhoven |
| 1999 – 2002 | Promotie onderzoek |
| 2002 – 2007 | Opleiding tot longarts: Catharina ziekenhuis Eindhoven |
| 2008 – heden | Longarts: Medisch Spectrum Twente, Enschede |
Publicaties
Proefschrift
“Exhaled hydrogen peroxide in chronic obstructive pulmonary disease“
Promotie: Nijmegen, 3 december 2003
Promotor: Prof. Dr. P.N.R. Dekhuijzen
Co-promotor: Dr. F.W.J.M. Smeenk
van Veelen E, van Beurden WJC. De Stem Interval Test: Luidroepend maar weinigzeggend?
Stem- spraak- en taalpathologie 1996; 4: 255-266.
van Beurden WJC, Dekhuijzen PNR, Creemers JPHM, Harff GA, van den Bosch MJA, Smeenk FWJM. Variation of exhaled hydrogen peroxide in stable COPD patients and matched healthy persons over time. Eur Respir J 2001; 18: 148s.
van Beurden WJC, Harff GA, Dekhuijzen PNR, Salden P, Creemers JPHM, Smeenk FWJM. The effect of inhaled corticosteroids on hydrogen peroxide exhalation in stable COPD patients. Eur Respir J 2001; 18: 337s.
van Beurden WJC, Harff GA, van den Bosch MJA, Dekhuijzen PNR, Creemers JPHM, Smeenk FWJM. A new method for measuring hydrogen peroxide concentration in exhaled air in stable COPD patients: reproducibility and stability. Eur Respir J 2001; 18: 460s.
van Beurden WJC, Harff GA, Dekhuijzen PNR, van den Bosch MJA, Creemers JPHM, Smeenk FWJM. An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respir Med 2002; 96: 197-203.
van Beurden WJC, Dekhuijzen PNR, Harff GA, Smeenk FWJM. Variability of exhaled hydrogen peroxide in stable COPD patients and matched healthy controls. Respiration 2002; 69: 211-216.
van Beurden WJC, Dekhuijzen PNR, Smeenk FWJM. Exhaled biomarkers in COPD: their potential role in diagnosis, treatment and prognosis. Modaldi Archives of Chest Disease 2002; 57: 258-267.
van Beurden WJC, Wielders PLML, Scheepers PJT, van Herwaarden CLA, Dekhuijzen PNR.Superoxide production by peripheral polymorphonuclear leukocytes in patients with COPD. Respir Med; 2003 96: 197-203.
van Beurden WJC, Harff GA, Dekhuijzen PNR, van der Poel-Smet SM, Smeenk FWJM. Effects of inhaled corticosteroids with different lung deposition on exhaled hydrogen peroxide in stable COPD patients. Respiration 2003; 70: 242-248.
Dekhuijzen PNR, van Beurden WJR. The role of N-acetylcysteine in the management of COPD. Int J Chron Obstr Pulmon Dis 2006; 1: 99-106.
Horváth J, Hunt J, Barnes PJ, Alving K,Antczak A, Baraldi E, Becher G, van Beurden WJC. Exhaled breath condensate methodological recommendations and unresolved questions. Eur Respir J 2005; 26: 523-548.